Literature DB >> 35604574

Atypical anti-NMDA receptor encephalitis associated with varicella zoster virus infection.

Nabli Fatma1, Saied Zakaria2, Zouari Mourad1, Belal Samir1, Ben Sassi Samia1.   

Abstract

The triggering effect of herpes simplex virus infection on the development of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is now well established. However, there are very few reports that has linked a varicella zoster virus (VZV) reactivation with anti-NMDAR encephalitis. In this report, we describe a case of a 57-year-old man presented with atypical clinical presentation of anti-NMDAR encephalitis with gait ataxia, complete ophtalmoplegia, and abolished reflexes followed by drowsiness and confusion. Initial diagnosis of Bickerstaff's brainstem encephalitis was suspected. Few days later, the patient developed herpes zoster in a localized right T1-T2 dermatome. Cerebrospinal fluid (CSF) polymerase chain reaction (PCR) for VZV was negative. CSF anti-NMDA antibodies were proved positive. A diagnosis of anti-NMDAR encephalitis with concomitant VZV skin reactivation was retained. Favorable outcome with combined antiviral treatment and immunomodulatory therapy was observed. Concomitant VZV reactivation with autoimmune encephalitis is possible. Prognosis and therapeutic options in this rare condition remain to be clarified.
© 2022. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Anti-NMDA receptor antibodies; Ataxia; Bickerstaff brainstem encephalitis; Encephalitis; Herpes zoster; Nervous system; Ophtalmoplegia; Varicella zoster virus

Mesh:

Year:  2022        PMID: 35604574     DOI: 10.1007/s13365-022-01080-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  8 in total

Review 1.  Ophthalmoplegia and flaccid paraplegia in a patient with anti-NMDA receptor encephalitis: a case report and literature review.

Authors:  Yuichi Ishikawa; Ken Ikeda; Kiyoko Murata; Takehisa Hirayama; Takanori Takazawa; Masaru Yanagihashi; Osamu Kano; Kiyokazu Kawabe; Yukitoshi Takahashi; Yasuo Iwasaki
Journal:  Intern Med       Date:  2013       Impact factor: 1.271

2.  VZV brainstem encephalitis triggers NMDA receptor immunoreaction.

Authors:  Wolf-Rüdiger Schäbitz; Andreas Rogalewski; Christoph Hagemeister; Christian G Bien
Journal:  Neurology       Date:  2014-11-05       Impact factor: 9.910

3.  [Case of herpes zoster associated Guillain-Barré syndrome with a relapse of eruptions after intravenous immunoglobulin therapy].

Authors:  Yuriko Nagane; Kimiaki Utsugisawa; Daiji Obara
Journal:  Rinsho Shinkeigaku       Date:  2006-09

4.  Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.

Authors:  S M Gregoire; V van Pesch; S Goffette; A Peeters; C J M Sindic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

5.  Clinical application of viral cerebrospinal fluid PCR testing for diagnosis of central nervous system disorders: a retrospective 11-year experience.

Authors:  Michael Kleines; Simone Scheithauer; Johannes Schiefer; Martin Häusler
Journal:  Diagn Microbiol Infect Dis       Date:  2014-08-06       Impact factor: 2.803

6.  Bickerstaff's encephalitis.

Authors:  Emma Horton; Sanjay Krishnamoorthy; Lucy Reynolds
Journal:  BMJ Case Rep       Date:  2014-07-30

7.  Complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.972

Review 8.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.